| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |